Pursuant to Regulation 30 of the SEBI LODR, 2015 we wish to inform you that, on the recommendation of NRC committee and Board approved appointment of Mr. Deepak Shukla as Chief Executive -API Business in capacity of SMP wef from July 28, 2025

pdf

RPG Life Sciences Ltd.

25 Jul 2025

2230.10

-0.07%

Company Update

RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release

pdf

RPG Life Sciences Ltd.

25 Jul 2025

2230.10

-0.07%

Result

RPG Life Sciences Ltd - 532983 - Unaudited Financial Result For The Quarter Ended On June …

BSE India

Unaudited financial result for the quarter ended on June 30, 2025

pdf

RPG Life Sciences Ltd.

25 Jul 2025

2230.10

-0.07%

Board Meeting

RPG Life Sciences Ltd - 532983 - Board Meeting Outcome for Outcome Of The Board Meeting …

BSE India

In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held on Friday, July 25, 2025 inter-alia considered and unanimously approved the following agenda items: 1. Unaudited Financial Results: The Unaudited Financial Results along with Limited Review Report of the Statutory Auditors thereon are enclosed herewith in terms of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. Revision in the Policy for Determination of Materiality of Events: Revision in the policy for Determination of Materiality of Events in accordance with the amended SEBI (Listing Obligations and Disclosure Requirements), 2015. The aforesaid amended policy shall be made available on the Company''s website at www.rpglifesciences.com_policies

pdf

RPG Life Sciences Ltd.

18 Jul 2025

2230.10

-0.07%

Board Meeting

RPG Life Sciences Ltd - 532983 - Board Meeting Intimation for Board Meeting Intimation To Consider …

BSE India

RPG Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2025 ,inter alia, to consider and approve Board Meeting Intimation to Consider and Approve Unaudited Financial Results for the quarter Ended June 30, 2025

pdf